RSS

MONI Moon Equity Hldgs Corp

Last Post: 09/05/23
Followers: 78
Posts Today: 0
Views Today: 6377

MONI Stock Quote & Tools

$0.0105 ▼ -0.0004 (-3.24%) As of Nov 13, 3:40 PM EST
Last0.0105
$ Chg-0.0004
Open0.0103
High0.0110
Beta1.3685
Year High0.021
Market Cap7.76M
P/B Ratio—
EPS—
Avg Vol (30d)5.03M
Volume2.03M
% Chg-3.24%
Prev Close0.0108
Low0.0095
VWAP0.00997
Year Low0.002
Total Shares742.51M
Shares Out742.51M
Float735.09M
ExchangeOTCID
Industrials Industrial Conglomerates

MONI Stock Message Board Discussion

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 146

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 53

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

Statkraft Secures Long-term Financing for Renewables Growth

Updated Category News Views 181

Statkraft's Commitment to Renewable Energy Statkraft AS is taking a significant step forward in its mission to lead in sustainable energy production. The company has recently entered into a long-term loan agreement with the Nordic Investment Bank (NIB), securing a substantial sum that will enhance its renewable energy initiatives. This strategic move underlines...

Continue Reading
New Insights on Xywav Efficacy in Narcolepsy Treatment Revealed

Updated Category News Views 469

Important Developments in Narcolepsy Treatment Jazz Pharmaceuticals plc (Nasdaq: JAZZ) released compelling Phase 4 data on Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, focusing on its effectiveness in treating narcolepsy. The latest findings were shared at a notable sleep conference, highlighting Xywav's unique benefits, particularly for...

Continue Reading
Xerox Holdings Corporation Faces Class Action Lawsuit Update

Updated Category News Views 308

Xerox Holdings Corporation Faces Class Action Lawsuit Update As awareness grows about the evolving corporate landscape, the law firm Kirby McInerney LLP is calling attention to a class action lawsuit filed on behalf of investors in Xerox Holdings Corporation (NASDAQ:XRX). This legal action seeks to protect the rights of those who purchased securities during a specific...

Continue Reading
Dornan Law Team Enhances Defense Services with New Hire

Updated Category News Views 118

Dornan Law Team Welcomes Esteemed Attorney Ryan Crnkovich Dornan Law Team, a renowned law firm dedicated to outstanding client-centered representation, is excited to announce the addition of Attorney Ryan Crnkovich to its team. With a rich background in criminal defense, military justice, and federal law, Crnkovich enhances the firm's ability to provide top-tier advocacy....

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 637

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading